1. Home
  2. ARTL vs IBG Comparison

ARTL vs IBG Comparison

Compare ARTL & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.31

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

IBG

Innovation Beverage Group Limited Ordinary Shares

HOLD

Current Price

$3.73

Market Cap

3.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
IBG
Founded
2011
2018
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARTL
IBG
Price
$1.31
$3.73
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
28.9K
162.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.30
52 Week High
$28.60
$6.50

Technical Indicators

Market Signals
Indicator
ARTL
IBG
Relative Strength Index (RSI) 40.83 56.86
Support Level $0.90 $0.53
Resistance Level $1.85 $5.12
Average True Range (ATR) 0.14 0.68
MACD -0.01 -0.04
Stochastic Oscillator 34.78 21.65

Price Performance

Historical Comparison
ARTL
IBG

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About IBG Innovation Beverage Group Limited Ordinary Shares

Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.

Share on Social Networks: